@article{articledc48faa1,
title   = {Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial},
author = {Crippa, José Alexandre de Souza and Pacheco, Júlia Cozar and Zuardi, Antônio Waldo and Guimarães, Francisco Silveira and Campos, Alline Cristina de and Osório, Flávia de Lima and Loureiro, Sonia Regina and Santos, Rafael Guimarães dos and souza, José Diogo dos Santos and Ushirohira, Juliana Mayumi and Ferreira, Rafael Rinaldi and Costa, Karla Cristinne Mancini and Scomparin, Davi Silveira and Scarante, Franciele Franco and Santos, Isabela Pires dos and Mechoulam, Raphael and Kapczinski, Flávio and Fonseca, Benedito Antonio Lopes da and Esposito, Danillo Lucas Alves and Passos, Afonso Dinis Costa and Dal-Fabbro, Amaury Lelis and Bellissimo-Rodrigues, Fernando and Arruda, Eurico and Scarpelini, Sandro and Andraus, Maristela Haddad and Nather Junior, Júlio Cesar and Wada, Danilo Tadao and Santos, Marcel Koenigkam and Santos, Antonio Carlos dos and Busatto Filho, Geraldo and Hallak, Jaime Eduardo Cecilio},
year = {2022},
doi = {10.1089/can.2021.0093},
journal   = {Cannabis And Cannabinoid Research}
}